News Column

BRIEF: Marrone Bio widens stock offering

June 2, 2014

By Dale Kasler, The Sacramento Bee

June 02--Davis biotech company Marrone Bio Innovations Inc. is expanding its proposed public stock offering.

In a filing Monday with the Securities and Exchange Commission, the maker of eco-friendly pesticides said it could sell up to 4.6 million shares for an estimated total of $41 million.

When it first filed to offer shares, Marrone Bio said the sale would generate a maximum of $35 million.

Marrone Bio said the company itself plans to sell 3.4 million shares. One of its shareholders, a Singapore investment firm called Syngenta Ventures, plans to sell 600,000 shares, bringing the offering to 4 million shares. In addition, the underwriting firms have been granted options to purchase another 600,000 shares, according to the SEC filing.

Marrone's share price closed Monday at $9.82, down $1.05, on the Nasdaq global market.

Marrone first went public last August in a deal that raised $57 million for the eight-year-old company.


(c)2014 The Sacramento Bee (Sacramento, Calif.)

Visit The Sacramento Bee (Sacramento, Calif.) at

Distributed by MCT Information Services

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Sacramento Bee (CA)

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters